Sun Pharmaceutical Industries today said that it has received the US Food and Drug Administration’s nod to market a generic version of alprazolam, an anti-anxiety drug, in the US market. (Source: The Economic Times Healthcare and Biotech News)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Lannett Company, Inc. (NYSE AMEX: LCI) announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application ( ANDA) for Phentermine Hydrochloride Blue/White Seed Capsules USP, 30 mg, the generic equivalent of Sandoz, Inc.’s Reference Listed Drug (RLD) Phentermine Hydrochloride Capsules USP, 30 mg. According to Wolters Kluwer, U.S. sales of Phentermine Hydrochloride Capsules USP, 30 mg (more…)
Lannett Company, Inc. (Amex:LCI) announced it has received approval from the U.S. Food and Drug Administration (FDA) for the company’s supplemental Abbreviated New Drug Application (ANDA) of Phentermine Hydrochloride Capsules 30 mg. The company expects to commence marketing this product immediately. Phentermine Hydrochloride (HCl) is indicated for the short-term management of obesity. [cl ick link for full article] (Source: Obesity / Weight Loss (more…)
Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: BRL), today announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its application to manu facture and market ageneric version of Pfizer Inc.’s XANAX XR(R) (Alprazolam Extended-Release)Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. The Company intends to launch itsproduct immediately. [click link for full article] (Source: Psychology / Psychiatry (more…)
Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: BRL), today announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its application to manufacture and market ageneric version of Pfizer Inc.’s XANAX XR(R) (Alprazolam Extended-Release)Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. The Company intends to launch itsproduct immediately. [click link for full article] (Source: Health N ews from (more…)
Global Pharmaceuticals Division to Launch
HAYWARD, Calif.–(HSMN NewsFeed)–IMPAX Laboratories, Inc. (OTC:IPXL ) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company’s Abbreviated New Drug Applicatio… Biopharmaceuticals, Generics, FDAIMPAX Laboratories, Xanax, Alprazolam, Xanax XR, Pharmaci a (Source: HSMN NewsFeed)
Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Alprazolam orally disintegrating tablets. Distribution of the product will commence immediately. (Source: Pharmaceutical Online News)
MedWorm Message: Get the v ery latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative (more…)
Lannett Company, Inc. (Amex:LCI) announced it has received approval from the U.S. Food and Drug Administration (FDA) for the company’s supplemental Abbreviated New Drug Application (ANDA) of Phentermine Hydrochloride Capsules 30 mg. The company expects to commence marketing th is product immediately. Phentermine Hydrochloride (HCl) is indicated for the short-term management of obesity. [click link for full article] (Source: Obesity / Weight Loss (more…)
Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: BRL), today announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its application to manufacture and market ageneric version of Pfiz er Inc.’s XANAX XR(R) (Alprazolam Extended-Release)Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. The Company intends to launch itsproduct immediately. [click link for full article] (Source: Health News from (more…)
Global Pharmaceuticals Division to Launch
HAYWARD, Calif.– (HSMN NewsFeed)–IMPAX Laboratories, Inc. (OTC:IPXL ) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company’s Abbreviated New Drug Applicatio… Biopharmaceuticals, Generics, FDAIMPAX Laboratories, Xanax, Alprazolam, Xanax XR, Pharmacia (Source: HSMN NewsFeed)